Observations with Rabenid in patients with locomotor disease.
By examining 139 patients suffering from locomotor diseases the author could observe the characteristic accompanying diseases as well as high uric acid level in 40 cases. She analyses the current opinions on hyperuricaemia and reports on her observations with uricosuric and antithrombotic coated Rabenid tablet (RG). She found sulfinpyrazone to be effective and valuable in the examined indication field.
Konrád
K
K
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy; D002986:Clinical Trials as Topic; D005260:Female; D006073:Gout / Q000097:blood / Q000188:drug therapy; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009468:Neuromuscular Diseases / Q000188:drug therapy*; D013442:Sulfinpyrazone / Q000627:therapeutic use*; D014527:Uric Acid / Q000097:blood
D014527:Uric Acid; D013442:Sulfinpyrazone